Paper584243
Synergism with aminoglycosides of penicillin, ampicillin and vancomycin against non-enterococcal group-D streptococci and viridans streptococci.
Watanakunakorn C and 1 other. J Med Microbiol, 1977. Cited by 30 papers, by iCite.
Cite this record
ConductScience Library. Synergism with aminoglycosides of penicillin, ampicillin and vancomycin against non-enterococcal group-D streptococci and viridans streptococci. Papers, record 584243. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/584243
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Synergism with aminoglycosides of penicillin, ampicillin and vancomycin against non-enterococcal group-D streptococci and viridans streptococci.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ampicillin | Major topic |
| Penicillins | Major topic |
| Streptococcaceae | Major topic |
| Streptococcus | Major topic |
| Vancomycin | Major topic |
| Aminoglycosides | |
| Anti-Bacterial Agents | |
| Blood | |
| Drug Synergism | |
| Endocarditis, Bacterial | |
| Humans | |
| Penicillin Resistance | |
| Sepsis | |
| Species Specificity |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42057897 | CoNS blood culture isolates from very preterm infants: antibiotic susceptibility, synergy testing and mecA gene expression. | JAC Antimicrob Resist | 2026 | https://conductscience.org/library/papers/42057897 | PubMed |
| 41984450 | Intrawound Tobramycin Plus Vancomycin to Prevent Surgical Site Infection in Tibial Fractures: The TOBRA Randomized Clinical Trial. | JAMA | 2026 | https://conductscience.org/library/papers/41984450 | PubMed |
| 17371822 | High-level gentamicin resistance mediated by a Tn4001-like transposon in seven nonclonal hospital isolates of Streptococcus pasteurianus. | Antimicrob Agents Chemother | 2007 | https://conductscience.org/library/papers/17371822 | PubMed |
| 6772095 | Bioassay for determination of vancomycin in the presence of rifampin or aminoglycosides. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6772095 | PubMed |
| 3643772 | In vitro studies simultaneously examining effect of oxacillin on uptake of radiolabeled streptomycin and on associated bacterial lethality in Staphylococcus aureus. | Antimicrob Agents Chemother | 1986 | https://conductscience.org/library/papers/3643772 | PubMed |
| 2318216 | Vancomycin-aminoglycoside combinations in therapy of endocarditis caused by Enterococcus species and Streptococcus bovis. | Eur J Clin Microbiol Infect Dis | 1990 | https://conductscience.org/library/papers/2318216 | PubMed |
| 98452 | An analysis of group D streptococci recovered from cancer patients. | Infection | 1978 | https://conductscience.org/library/papers/98452 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/584243
GET https://conductscience.org/api/papers/v1/584243/authors